Abstract
Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 617-618 |
| Number of pages | 2 |
| Journal | Annals of internal medicine |
| Volume | 118 |
| Issue number | 8 |
| State | Published - Apr 15 1993 |
ASJC Scopus subject areas
- Internal Medicine
Fingerprint
Dive into the research topics of 'Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS